GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Malaysian Genomics Resource Centre Bhd (XKLS:0155) » Definitions » Cash Ratio

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Cash Ratio : 0.08 (As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Malaysian Genomics Resource Centre Bhd Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Malaysian Genomics Resource Centre Bhd's Cash Ratio for the quarter that ended in Dec. 2024 was 0.08.

Malaysian Genomics Resource Centre Bhd has a Cash Ratio of 0.08. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.

The historical rank and industry rank for Malaysian Genomics Resource Centre Bhd's Cash Ratio or its related term are showing as below:

XKLS:0155' s Cash Ratio Range Over the Past 10 Years
Min: 0.07   Med: 0.74   Max: 12.34
Current: 0.08

During the past 13 years, Malaysian Genomics Resource Centre Bhd's highest Cash Ratio was 12.34. The lowest was 0.07. And the median was 0.74.

XKLS:0155's Cash Ratio is ranked worse than
92.79% of 222 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.105 vs XKLS:0155: 0.08

Malaysian Genomics Resource Centre Bhd Cash Ratio Historical Data

The historical data trend for Malaysian Genomics Resource Centre Bhd's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Malaysian Genomics Resource Centre Bhd Cash Ratio Chart

Malaysian Genomics Resource Centre Bhd Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Dec24
Cash Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.60 - 3.18 12.34 0.08

Malaysian Genomics Resource Centre Bhd Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Mar24 Jun24 Sep24 Dec24
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.50 0.17 0.07 0.02 0.08

Competitive Comparison of Malaysian Genomics Resource Centre Bhd's Cash Ratio

For the Diagnostics & Research subindustry, Malaysian Genomics Resource Centre Bhd's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Malaysian Genomics Resource Centre Bhd's Cash Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Malaysian Genomics Resource Centre Bhd's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Malaysian Genomics Resource Centre Bhd's Cash Ratio falls into.


;
;

Malaysian Genomics Resource Centre Bhd Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Malaysian Genomics Resource Centre Bhd's Cash Ratio for the fiscal year that ended in Dec. 2024 is calculated as:

Cash Ratio (A: Dec. 2024 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=0.271/3.575
=0.08

Malaysian Genomics Resource Centre Bhd's Cash Ratio for the quarter that ended in Dec. 2024 is calculated as:

Cash Ratio (Q: Dec. 2024 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=0.271/3.575
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Malaysian Genomics Resource Centre Bhd  (XKLS:0155) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Malaysian Genomics Resource Centre Bhd Cash Ratio Related Terms

Thank you for viewing the detailed overview of Malaysian Genomics Resource Centre Bhd's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Malaysian Genomics Resource Centre Bhd Business Description

Traded in Other Exchanges
N/A
Address
Jalan Teknologi 3/6, 8F, Taman Sains Selangor 1, Kota Damansara (PJU5), Petaling Jaya, SGR, MYS, 47810
Malaysian Genomics Resource Centre Bhd is a Malaysia-based company. The company's principal activities include enabling personalized and precision medicine through genetics, genomics, immunotherapy, and biopharmaceutical services, as well as investment holding. It offers genome sequencing and analysis (GSA) services, and genetic screening services (GSS). GSA services involve the sequencing and analysis of the DNA of humans, animals, plants, and microbes for biological information. The company provides GSS services through its own range of genetic screening tests under the brand Dtect which screens human DNA for genetic markers related to diseases and health conditions. It is also engaged in Research, development, and distribution of biopharmaceutical products and services.

Malaysian Genomics Resource Centre Bhd Headlines

No Headlines